Boston Scientific Corp (XTER:BSX)
€ 86.5 -0.5 (-0.57%) Market Cap: 126.52 Bil Enterprise Value: 134.81 Bil PE Ratio: 74.93 PB Ratio: 6.45 GF Score: 79/100

Boston Scientific Corp Investor Day Transcript

Jun 26, 2019 / 11:30AM GMT
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

(presentation)

Good morning, everyone. We hope that you found that video half as inspiring as we do. We actually produce that annually for our internal R&D awards, and those products, plus the rest of our portfolio, are what enable us at Boston Scientific to improve the lives of 30 million patients each year and what drive us each and every day.

My name is Susie Lisa. I'm the Vice President of Investor Relations. And on behalf of the entire IR team, we're very grateful that you chose to spend your June morning in New York with us here today and those virtually with us on the web. Thank you very much, and we'll do our very best to lay out a really exciting day of our growth prospects and pipeline and our people and why we're excited for the long-term outlook.

Before we get into it, I do have some housekeeping items to go through. First, the usual safe harbor and risk factors apply. We encourage you to consult our latest SEC filings and 10-Q and 10-K, which have a discussion -- full discussion of all the risk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot